Pharmaceuticals Companies By Shares Shorted

Number Of Shares Shorted
Number Of Shares ShortedEfficiencyMarket RiskExp Return
1TLRY Tilray Inc
101.64 M
(0.08)
 3.15 
(0.24)
2PFE Pfizer Inc
67.62 M
 0.03 
 1.36 
 0.04 
3ZOM Zomedica Pharmaceuticals Corp
46.06 M
(0.04)
 3.57 
(0.16)
4TEVA Teva Pharma Industries
30.34 M
 0.03 
 1.87 
 0.05 
5MRK Merck Company
27.26 M
(0.14)
 1.64 
(0.22)
6VTRS Viatris
26.31 M
 0.04 
 1.84 
 0.08 
7CORT Corcept Therapeutics Incorporated
21.51 M
 0.23 
 2.39 
 0.55 
8BMY Bristol Myers Squibb
20.03 M
 0.21 
 2.12 
 0.46 
9JNJ Johnson Johnson
19.74 M
 0.13 
 1.05 
 0.13 
10SAVA Cassava Sciences
17.63 M
 0.16 
 9.89 
 1.57 
11PHAT Phathom Pharmaceuticals
17.22 M
 0.10 
 4.09 
 0.42 
12OCUL Ocular Therapeutix
16.19 M
 0.06 
 3.12 
 0.19 
13BHC Bausch Health Companies
14.78 M
 0.06 
 4.12 
 0.25 
14RPRX Royalty Pharma Plc
14.57 M
 0.05 
 1.29 
 0.07 
15CTXR Citius Pharmaceuticals
12.77 M
(0.17)
 5.28 
(0.88)
16ELAN Elanco Animal Health
12.42 M
 0.07 
 2.36 
 0.16 
17OMER Omeros
11.93 M
(0.04)
 4.17 
(0.15)
18LQDA Liquidia Technologies
11.84 M
(0.01)
 5.35 
(0.03)
19GSK GlaxoSmithKline PLC ADR
11.69 M
 0.03 
 1.60 
 0.05 
20INVA Innoviva
11.69 M
 0.19 
 1.25 
 0.24 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up. If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.